Showing results (21-30 of 86) with videos related to
Sort By:
Pageof 9
British Journal of Clinical Pharmacology|November 20, 2020
Confounding factors in exposure-response analyses and mitigation strategies for monoclonal antibodies in oncologySonoko Kawakatsu, René Bruno, Matts Kågedal, et al.Regulatory Toxicology and Pharmacology : RTP|November 18, 2004
Evaluation of a surrogate antibody for preclinical safety testing of an anti-CD11a monoclonal antibodyJanet Clarke, Will Leach, Susanne Pippig, et al.The Journal of the Association of Physicians of India|April 30, 2014
Leukemoid reaction, a rare manifestation of autoimmune hemolytic anemia in a case of small duct primary sclerosing cholangitisKaustubh D Salagre, Ravindra Nath Sahay, Anuja Patil, et al.Pharmaceutical Research|July 20, 2005
Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasisChee M Ng, Amita Joshi, Russell L Dedrick, et al.Journal of Clinical Pharmacology|February 25, 2015
Challenges and considerations for development of therapeutic proteins in pediatric patientsYi Zhang, Xiaohui Wei, Gaurav Bajaj, et al.Journal of Clinical Pharmacology|March 22, 2005
Population pharmacokinetics of efalizumab (humanized monoclonal anti-CD11a antibody) following long-term subcutaneous weekly dosing in psoriasis subjectsYu-Nien Sun, Jian-Feng Lu, Amita Joshi, et al.Current Drug Delivery|October 15, 2025
Peptide-Loaded Nanoparticles: A Precision Approach to Breast Cancer TreatmentLina Eltaib, Mashael N Alanazi, Mudasir Maqbool, et al.Journal of Chromatographic Science|September 13, 2015
Impact of Ternary Solvent System in Stability-Indicating Assay Method of Bambuterol: Design of Experiments ApproachA Abiramasundari, Amita Joshi, Rahul Joshi, et al.Indian Journal of Pediatrics|November 8, 2002
Alagille syndromeHarshalee Shendge, Milind S Tullu, Asha Shenoy, et al.Journal of Clinical Pharmacology|October 15, 2013
Prediction of overall survival or progression free survival by disease control rate at week 8 is independent of ethnicity: Western versus Chinese patients with first-line non-small cell lung cancer treated with chemotherapy with or without bevacizumabLaurent Claret, Manish Gupta, Kelong Han, et al.Pageof 9